These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

691 related items for PubMed ID: 25042938

  • 1. Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy.
    Ulldemolins M, Vaquer S, Llauradó-Serra M, Pontes C, Calvo G, Soy D, Martín-Loeches I.
    Crit Care; 2014 Jun 23; 18(3):227. PubMed ID: 25042938
    [Abstract] [Full Text] [Related]

  • 2. Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy.
    Seyler L, Cotton F, Taccone FS, De Backer D, Macours P, Vincent JL, Jacobs F.
    Crit Care; 2011 Jun 23; 15(3):R137. PubMed ID: 21649882
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Case-control study of drug monitoring of β-lactams in obese critically ill patients.
    Hites M, Taccone FS, Wolff F, Cotton F, Beumier M, De Backer D, Roisin S, Lorent S, Surin R, Seyler L, Vincent JL, Jacobs F.
    Antimicrob Agents Chemother; 2013 Feb 23; 57(2):708-15. PubMed ID: 23147743
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Covariate determinants of effective dosing regimens for time-dependent beta-lactam antibiotics for critically ill patients.
    Kaska M, Havel E, Selke-Krulichova I, Safranek P, Bezouska J, Martinkova J.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep 23; 162(3):219-226. PubMed ID: 29582860
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Poor Correlation between Meropenem and Piperacillin Plasma Concentrations and Delivered Dose of Continuous Renal Replacement Therapy.
    Petersson J, Giske CG, Eliasson E.
    Antimicrob Agents Chemother; 2021 Mar 18; 65(4):. PubMed ID: 33495227
    [Abstract] [Full Text] [Related]

  • 19. An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy.
    Imani S, Buscher H, Day R, Gentili S, Jones GRD, Marriott D, Norris R, Sandaradura I.
    Eur J Clin Microbiol Infect Dis; 2018 Nov 18; 37(11):2171-2175. PubMed ID: 30120647
    [Abstract] [Full Text] [Related]

  • 20. Optimal Meropenem Dosing Regimens in Patients Undergoing Continuous Renal Replacement Therapy: Systematic Review and Monte Carlo Simulations.
    Charoensareerat T, Chaijamorn W, Kerdnimith P, Kosumwisaisakul N, Teeranaew P, Rungkitwattanakul D, Boonpeng A, Srisawat N, Pattharachayakul S.
    Blood Purif; 2023 Nov 18; 52(6):503-515. PubMed ID: 37231811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.